Efeitos do novo doador de óxido nítrico [Ru(terpy)(bdq)NO+]3+ sobre o músculo liso traqueal de ratos com asma experimental

Detalhes bibliográficos
Autor(a) principal: Castro, Patrícia Ferreira da Silva
Data de Publicação: 2015
Tipo de documento: Tese
Idioma: por
Título da fonte: Repositório Institucional da UFG
Texto Completo: http://repositorio.bc.ufg.br/tede/handle/tede/5117
Resumo: Nitric oxide is a potent bronchodilator and compounds capable of increasing its supply have demonstrated clinical interest in the treatment of obstructive airways diseases. This study evaluated and compared the mechanisms of relaxation of two nitric oxide donors, ruthenium complex [Ru(terpy)(bdq)NO+]3+ (TERPY) and sodium nitroprusside (SNP) in healthy isolated trachea, Sham group, or experimental model of asthma induced by ovalbumin in rats, OVA group. The isolated trachea was sectioned into rings and contracted with carbachol in an organ chamber for studying relaxation. The relaxing effect of TERPY and SNP was evaluated at increasing concentrations from 10 nM to 100 μM. Thus, we verified the contribution of the different types of K+ channels, the importance of sGC/cGMP pathway, the inhibition of PDEs (for IBMX, amrinone, rolipram and dypiridamole), the influence of the extra and intracellular Ca2+ sources (for cyclopiazonic acid) and the influence of the store and voltage operated calcium channels. Besides inhibition of COX (diclofenac), antagonism of leukotriene receptor (montelukast) and superoxide anion scavenger (TIRON). Analyses were performed under light microscopy for evidence of inflammatory infiltration and bronchoditation by TERPY in slices bronchioles of asthmatic animals. The results verified that sensitization with ovalbumin led to intense inflammatory process and hyperresponsives to carbachol in compared Sham group. TERPY and SNP led to the relaxation of tracheal smooth muscle preparations in a dependent-concentration mode in both groups. However, the maximum effect induced by TERPY was higher than the effect of SNP in Sham and OVA groups. The relaxation mechanism of TERPY in boht groups showed differences. In Sham group, TERPY relaxation by the activation of Kv, Kir, KCa and KATP channels, cGMP-independent mechanisms and by reduction of calcium influx by blocking the store and voltage operated calcium channels. In OVA group, TERPY acts through activation K+ channels, NO/GCs/GMP way and blocking the store and voltage operated calcium channels. The relaxing effect induced by SNP in OVA group was dependent of NO/GCs/GMP pathway, Kv, KCa and BKCa channels and blocking the store and voltage operated calcium channels. However, the activation of the enzyme sGC seems to be reduced in inflamed smooth muscle, as well as the role of the sarcoplasmic reticulum calcium pump. Diclofenac, montelukast and TIRON improved relaxation of the TERPY and SNP in OVA group. The TERPY is able to reverse the contraction of carbachol in asthmatic bronchioles. In conclusion, TERPY and SNP have their mechanisms of relaxation modified by the inflammatory process. However, this modification was not able to alter the pharmacological parameters potency and efficacy to TERPY. Since SNP has less efficacy effect in asthmatic tracheas. This may result from the lower participation of the enzyme sGC and reticular calcium pump, making TERPY a promising drug to reverse the narrowing of the airways.
id UFG-2_d5d7b146d27c7907d676f31237d3fd11
oai_identifier_str oai:repositorio.bc.ufg.br:tede/5117
network_acronym_str UFG-2
network_name_str Repositório Institucional da UFG
repository_id_str
spelling Rocha, Matheus LavorentiRocha , Matheus LavorentiJacomini , Luiza Cristina LacerdaFreitas, Jaqueline GleiceRezende, Kênnia RochaCosta, Elson AlvesCastro, Patrícia Ferreira da Silva2016-01-18T08:44:08Z2015-03-26CASTRO, P. F. S. Efeitos do novo doador de óxido nítrico [Ru(terpy)(bdq)NO+]3+ sobre o músculo liso traqueal de ratos com asma experimental. 2015. 135 f. Tese (Doutorado em Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2015.http://repositorio.bc.ufg.br/tede/handle/tede/5117Nitric oxide is a potent bronchodilator and compounds capable of increasing its supply have demonstrated clinical interest in the treatment of obstructive airways diseases. This study evaluated and compared the mechanisms of relaxation of two nitric oxide donors, ruthenium complex [Ru(terpy)(bdq)NO+]3+ (TERPY) and sodium nitroprusside (SNP) in healthy isolated trachea, Sham group, or experimental model of asthma induced by ovalbumin in rats, OVA group. The isolated trachea was sectioned into rings and contracted with carbachol in an organ chamber for studying relaxation. The relaxing effect of TERPY and SNP was evaluated at increasing concentrations from 10 nM to 100 μM. Thus, we verified the contribution of the different types of K+ channels, the importance of sGC/cGMP pathway, the inhibition of PDEs (for IBMX, amrinone, rolipram and dypiridamole), the influence of the extra and intracellular Ca2+ sources (for cyclopiazonic acid) and the influence of the store and voltage operated calcium channels. Besides inhibition of COX (diclofenac), antagonism of leukotriene receptor (montelukast) and superoxide anion scavenger (TIRON). Analyses were performed under light microscopy for evidence of inflammatory infiltration and bronchoditation by TERPY in slices bronchioles of asthmatic animals. The results verified that sensitization with ovalbumin led to intense inflammatory process and hyperresponsives to carbachol in compared Sham group. TERPY and SNP led to the relaxation of tracheal smooth muscle preparations in a dependent-concentration mode in both groups. However, the maximum effect induced by TERPY was higher than the effect of SNP in Sham and OVA groups. The relaxation mechanism of TERPY in boht groups showed differences. In Sham group, TERPY relaxation by the activation of Kv, Kir, KCa and KATP channels, cGMP-independent mechanisms and by reduction of calcium influx by blocking the store and voltage operated calcium channels. In OVA group, TERPY acts through activation K+ channels, NO/GCs/GMP way and blocking the store and voltage operated calcium channels. The relaxing effect induced by SNP in OVA group was dependent of NO/GCs/GMP pathway, Kv, KCa and BKCa channels and blocking the store and voltage operated calcium channels. However, the activation of the enzyme sGC seems to be reduced in inflamed smooth muscle, as well as the role of the sarcoplasmic reticulum calcium pump. Diclofenac, montelukast and TIRON improved relaxation of the TERPY and SNP in OVA group. The TERPY is able to reverse the contraction of carbachol in asthmatic bronchioles. In conclusion, TERPY and SNP have their mechanisms of relaxation modified by the inflammatory process. However, this modification was not able to alter the pharmacological parameters potency and efficacy to TERPY. Since SNP has less efficacy effect in asthmatic tracheas. This may result from the lower participation of the enzyme sGC and reticular calcium pump, making TERPY a promising drug to reverse the narrowing of the airways.O óxido nítrico é um potente broncodilatador e compostos capazes de aumentar a sua oferta têm demonstrado interesse clínico no tratamento das doenças obstrutivas das vias aéreas. Estee trabalho avaliou comparativamente os mecanismos de relaxamento de dois doadores de óxido nítrico, o complexo de rutênio [Ru(terpy)(bdq)NO+]3+ (TERPY) e o nitroprussiato de sódio (SNP) em traqueias isoladas de ratos saudáveis, grupo Sham, e com asma experimental induzida por ovalbumina, grupo OVA. As traqueias isoladas foram cortadas em anéis, montadas em banho para órgãos isolados e contraída com carbacol para estudo do relaxamento. O efeito relaxante do TERPY e do SNP foi avaliado em concentrações crescentes e cumulativas (10 nM a 100 μM). Foi verificada a participação dos diferentes tipos de canais de K+, a participação da via GCs/GMPc, inibição das PDEs (pelo IBMX, amrinona, rolipram e dipiridamol), a participação dos estoques internos de Ca2+ (pelo ácido ciclopiazônico), assim como a participação do influxo deste íon pelos canais de cálcio controlados por estoque e por voltagem, além da inibição da COX (pelo diclofenaco), do antagonismo dos receptores de leucotrienos (pelo montelucaste) e do sequestro dos íons superóxidos (pelo TIRON). Foram realizadas análises em microscopia de luz para comprovação da presença de infiltrado inflamatório e da broncodilatação exercida pelo TERPY em cortes de bronquíolos de animais asmáticos. Como resultados, verificou-se que a sensibilização com ovalbumina levou a um intenso processo inflamatório com migração celular e hiperreatividade ao carbacol. Evidenciou-se que o TERPY e o SNP relaxaram o músculo liso traqueal de forma concentração-dependente em ambos os grupos. Entretanto, o efeito máximo induzido pelo TERPY foi maior do que o do SNP tanto no grupo Sham quanto no OVA. O mecanismo de relaxamento do TERPY mostrou-se diferente entre os grupos. No grupo Sham, o TERPY exerce relaxamento por ativação dos canais Kv, Kir, KCa e KATP independentemente de GMPc e por redução do influxo de cálcio através do bloqueio dos canais de cálcio operados por voltagem e por estoque. No grupo OVA, o TERPY exerce seu efeito através da por ativação dos canais K+, via NO/GCs/GMP e redução do influxo de cálcio por bloqueio dos canais de cálcio operados por voltagem e operados por estoque. O efeito relaxante do SNP no grupo OVA ocorre através da ativação da via NO/GCs/GMPc, dos canais Kv, KCa e SKCa e por redução do influxo de cálcio pelos canais de cálcio operados por voltagem e operados por estoque. Entretanto, a ativação da enzima GCs parece estar reduzida em músculo liso inflamado, assim como o papel da bomba de cálcio do retículo sarcoplasmático. O diclofenaco, o montelucaste e o TIRON melhoraram o perfil de relaxamento tanto do TERPY quanto do SNP no grupo OVA. O TERPY é capaz de reverter a contração do carbacol em bronquíolos asmáticos. Em conclusão, tanto o SNP quanto o TERPY têm seus mecanismos de relaxamento modificados pelo processo inflamatório. Entretanto, esta modificação não foi capaz de alterar os parâmetros farmacológicos de potência e eficácia do TERPY. Já o SNP, tem menor eficácia em traqueias de ratos do grupo OVA e isso pode decorrer da menor participação da enzima GCs e da bomba de cálcio reticular, fazendo do TERPY uma droga promissora para reversão do estreitamento das vias aéreas.Submitted by Cláudia Bueno (claudiamoura18@gmail.com) on 2016-01-15T13:24:17Z No. of bitstreams: 2 Tese - Patrícia Ferreira da Silva Castro - 2015.pdf: 4272048 bytes, checksum: bb8709720dbc4fb91db81ca23004d59d (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2016-01-18T08:44:08Z (GMT) No. of bitstreams: 2 Tese - Patrícia Ferreira da Silva Castro - 2015.pdf: 4272048 bytes, checksum: bb8709720dbc4fb91db81ca23004d59d (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)Made available in DSpace on 2016-01-18T08:44:08Z (GMT). No. of bitstreams: 2 Tese - Patrícia Ferreira da Silva Castro - 2015.pdf: 4272048 bytes, checksum: bb8709720dbc4fb91db81ca23004d59d (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2015-03-26Fundação de Amparo à Pesquisa do Estado de Goiás - FAPEGapplication/pdfhttp://repositorio.bc.ufg.br/tede/retrieve/25202/Tese%20-%20Patr%c3%adcia%20Ferreira%20da%20Silva%20Castro%20-%202015.pdf.jpgporUniversidade Federal de GoiásPrograma de Pós-graduação em Ciências da Saúde (FM)UFGBrasilFaculdade de Medicina - FM (RG)http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessÓxido nítricoAsmaCompostos de rutênioTraqueiaCanais de potássioGuanilato ciclaseNitric oxideAsthmaRuthenium compoundsTracheaPotassium channelsGuanylate cyclaseCIENCIAS DA SAUDE::MEDICINAEfeitos do novo doador de óxido nítrico [Ru(terpy)(bdq)NO+]3+ sobre o músculo liso traqueal de ratos com asma experimentalEffects of new nitric oxide donor [Ru(terpy)(bdq)NO+]3+ on tracheal smooth muscle of rats with experimental asthamainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesis-10068643126177453106006006006001545772475950486338-969369452308786627-961409807440757778reponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGLICENSElicense.txtlicense.txttext/plain; charset=utf-82165http://repositorio.bc.ufg.br/tede/bitstreams/341c9a93-0bca-4971-8a24-c95bc3efe844/downloadbd3efa91386c1718a7f26a329fdcb468MD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849http://repositorio.bc.ufg.br/tede/bitstreams/2a94c7d9-ad86-4a97-9b3d-ab69461c35a0/download4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-822064http://repositorio.bc.ufg.br/tede/bitstreams/f4ce078f-5d7d-4e5d-90c4-a5ee5db4daf9/downloadef48816a10f2d45f2e2fee2f478e2fafMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-823148http://repositorio.bc.ufg.br/tede/bitstreams/a40ddc2c-abfb-4ea7-ab9b-f8c49359bf8c/download9da0b6dfac957114c6a7714714b86306MD54ORIGINALTese - Patrícia Ferreira da Silva Castro - 2015.pdfTese - Patrícia Ferreira da Silva Castro - 2015.pdfapplication/pdf4272048http://repositorio.bc.ufg.br/tede/bitstreams/dcadaa48-f954-49d9-a1e3-e3e065fe93c7/downloadbb8709720dbc4fb91db81ca23004d59dMD55TEXTTese - Patrícia Ferreira da Silva Castro - 2015.pdf.txtTese - Patrícia Ferreira da Silva Castro - 2015.pdf.txtExtracted Texttext/plain270102http://repositorio.bc.ufg.br/tede/bitstreams/4f436744-fa72-417c-a171-b5891ae5f411/download5e263194c614bec1e9a82794359cf0e7MD56THUMBNAILTese - Patrícia Ferreira da Silva Castro - 2015.pdf.jpgTese - Patrícia Ferreira da Silva Castro - 2015.pdf.jpgGenerated Thumbnailimage/jpeg2544http://repositorio.bc.ufg.br/tede/bitstreams/75b3df75-b602-45be-8377-e20d353e0e32/download9c1001d0c2cad66da621f0290adbdd41MD57tede/51172016-01-19 03:03:29.228http://creativecommons.org/licenses/by-nc-nd/4.0/Acesso Abertoopen.accessoai:repositorio.bc.ufg.br:tede/5117http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttp://repositorio.bc.ufg.br/oai/requesttasesdissertacoes.bc@ufg.bropendoar:2016-01-19T05:03:29Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)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
dc.title.por.fl_str_mv Efeitos do novo doador de óxido nítrico [Ru(terpy)(bdq)NO+]3+ sobre o músculo liso traqueal de ratos com asma experimental
dc.title.alternative.eng.fl_str_mv Effects of new nitric oxide donor [Ru(terpy)(bdq)NO+]3+ on tracheal smooth muscle of rats with experimental asthama
title Efeitos do novo doador de óxido nítrico [Ru(terpy)(bdq)NO+]3+ sobre o músculo liso traqueal de ratos com asma experimental
spellingShingle Efeitos do novo doador de óxido nítrico [Ru(terpy)(bdq)NO+]3+ sobre o músculo liso traqueal de ratos com asma experimental
Castro, Patrícia Ferreira da Silva
Óxido nítrico
Asma
Compostos de rutênio
Traqueia
Canais de potássio
Guanilato ciclase
Nitric oxide
Asthma
Ruthenium compounds
Trachea
Potassium channels
Guanylate cyclase
CIENCIAS DA SAUDE::MEDICINA
title_short Efeitos do novo doador de óxido nítrico [Ru(terpy)(bdq)NO+]3+ sobre o músculo liso traqueal de ratos com asma experimental
title_full Efeitos do novo doador de óxido nítrico [Ru(terpy)(bdq)NO+]3+ sobre o músculo liso traqueal de ratos com asma experimental
title_fullStr Efeitos do novo doador de óxido nítrico [Ru(terpy)(bdq)NO+]3+ sobre o músculo liso traqueal de ratos com asma experimental
title_full_unstemmed Efeitos do novo doador de óxido nítrico [Ru(terpy)(bdq)NO+]3+ sobre o músculo liso traqueal de ratos com asma experimental
title_sort Efeitos do novo doador de óxido nítrico [Ru(terpy)(bdq)NO+]3+ sobre o músculo liso traqueal de ratos com asma experimental
author Castro, Patrícia Ferreira da Silva
author_facet Castro, Patrícia Ferreira da Silva
author_role author
dc.contributor.advisor1.fl_str_mv Rocha, Matheus Lavorenti
dc.contributor.referee1.fl_str_mv Rocha , Matheus Lavorenti
dc.contributor.referee2.fl_str_mv Jacomini , Luiza Cristina Lacerda
dc.contributor.referee3.fl_str_mv Freitas, Jaqueline Gleice
dc.contributor.referee4.fl_str_mv Rezende, Kênnia Rocha
dc.contributor.referee5.fl_str_mv Costa, Elson Alves
dc.contributor.author.fl_str_mv Castro, Patrícia Ferreira da Silva
contributor_str_mv Rocha, Matheus Lavorenti
Rocha , Matheus Lavorenti
Jacomini , Luiza Cristina Lacerda
Freitas, Jaqueline Gleice
Rezende, Kênnia Rocha
Costa, Elson Alves
dc.subject.por.fl_str_mv Óxido nítrico
Asma
Compostos de rutênio
Traqueia
Canais de potássio
Guanilato ciclase
topic Óxido nítrico
Asma
Compostos de rutênio
Traqueia
Canais de potássio
Guanilato ciclase
Nitric oxide
Asthma
Ruthenium compounds
Trachea
Potassium channels
Guanylate cyclase
CIENCIAS DA SAUDE::MEDICINA
dc.subject.eng.fl_str_mv Nitric oxide
Asthma
Ruthenium compounds
Trachea
Potassium channels
Guanylate cyclase
dc.subject.cnpq.fl_str_mv CIENCIAS DA SAUDE::MEDICINA
description Nitric oxide is a potent bronchodilator and compounds capable of increasing its supply have demonstrated clinical interest in the treatment of obstructive airways diseases. This study evaluated and compared the mechanisms of relaxation of two nitric oxide donors, ruthenium complex [Ru(terpy)(bdq)NO+]3+ (TERPY) and sodium nitroprusside (SNP) in healthy isolated trachea, Sham group, or experimental model of asthma induced by ovalbumin in rats, OVA group. The isolated trachea was sectioned into rings and contracted with carbachol in an organ chamber for studying relaxation. The relaxing effect of TERPY and SNP was evaluated at increasing concentrations from 10 nM to 100 μM. Thus, we verified the contribution of the different types of K+ channels, the importance of sGC/cGMP pathway, the inhibition of PDEs (for IBMX, amrinone, rolipram and dypiridamole), the influence of the extra and intracellular Ca2+ sources (for cyclopiazonic acid) and the influence of the store and voltage operated calcium channels. Besides inhibition of COX (diclofenac), antagonism of leukotriene receptor (montelukast) and superoxide anion scavenger (TIRON). Analyses were performed under light microscopy for evidence of inflammatory infiltration and bronchoditation by TERPY in slices bronchioles of asthmatic animals. The results verified that sensitization with ovalbumin led to intense inflammatory process and hyperresponsives to carbachol in compared Sham group. TERPY and SNP led to the relaxation of tracheal smooth muscle preparations in a dependent-concentration mode in both groups. However, the maximum effect induced by TERPY was higher than the effect of SNP in Sham and OVA groups. The relaxation mechanism of TERPY in boht groups showed differences. In Sham group, TERPY relaxation by the activation of Kv, Kir, KCa and KATP channels, cGMP-independent mechanisms and by reduction of calcium influx by blocking the store and voltage operated calcium channels. In OVA group, TERPY acts through activation K+ channels, NO/GCs/GMP way and blocking the store and voltage operated calcium channels. The relaxing effect induced by SNP in OVA group was dependent of NO/GCs/GMP pathway, Kv, KCa and BKCa channels and blocking the store and voltage operated calcium channels. However, the activation of the enzyme sGC seems to be reduced in inflamed smooth muscle, as well as the role of the sarcoplasmic reticulum calcium pump. Diclofenac, montelukast and TIRON improved relaxation of the TERPY and SNP in OVA group. The TERPY is able to reverse the contraction of carbachol in asthmatic bronchioles. In conclusion, TERPY and SNP have their mechanisms of relaxation modified by the inflammatory process. However, this modification was not able to alter the pharmacological parameters potency and efficacy to TERPY. Since SNP has less efficacy effect in asthmatic tracheas. This may result from the lower participation of the enzyme sGC and reticular calcium pump, making TERPY a promising drug to reverse the narrowing of the airways.
publishDate 2015
dc.date.issued.fl_str_mv 2015-03-26
dc.date.accessioned.fl_str_mv 2016-01-18T08:44:08Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv CASTRO, P. F. S. Efeitos do novo doador de óxido nítrico [Ru(terpy)(bdq)NO+]3+ sobre o músculo liso traqueal de ratos com asma experimental. 2015. 135 f. Tese (Doutorado em Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2015.
dc.identifier.uri.fl_str_mv http://repositorio.bc.ufg.br/tede/handle/tede/5117
identifier_str_mv CASTRO, P. F. S. Efeitos do novo doador de óxido nítrico [Ru(terpy)(bdq)NO+]3+ sobre o músculo liso traqueal de ratos com asma experimental. 2015. 135 f. Tese (Doutorado em Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2015.
url http://repositorio.bc.ufg.br/tede/handle/tede/5117
dc.language.iso.fl_str_mv por
language por
dc.relation.program.fl_str_mv -1006864312617745310
dc.relation.confidence.fl_str_mv 600
600
600
600
dc.relation.department.fl_str_mv 1545772475950486338
dc.relation.cnpq.fl_str_mv -969369452308786627
dc.relation.sponsorship.fl_str_mv -961409807440757778
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Goiás
dc.publisher.program.fl_str_mv Programa de Pós-graduação em Ciências da Saúde (FM)
dc.publisher.initials.fl_str_mv UFG
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Faculdade de Medicina - FM (RG)
publisher.none.fl_str_mv Universidade Federal de Goiás
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFG
instname:Universidade Federal de Goiás (UFG)
instacron:UFG
instname_str Universidade Federal de Goiás (UFG)
instacron_str UFG
institution UFG
reponame_str Repositório Institucional da UFG
collection Repositório Institucional da UFG
bitstream.url.fl_str_mv http://repositorio.bc.ufg.br/tede/bitstreams/341c9a93-0bca-4971-8a24-c95bc3efe844/download
http://repositorio.bc.ufg.br/tede/bitstreams/2a94c7d9-ad86-4a97-9b3d-ab69461c35a0/download
http://repositorio.bc.ufg.br/tede/bitstreams/f4ce078f-5d7d-4e5d-90c4-a5ee5db4daf9/download
http://repositorio.bc.ufg.br/tede/bitstreams/a40ddc2c-abfb-4ea7-ab9b-f8c49359bf8c/download
http://repositorio.bc.ufg.br/tede/bitstreams/dcadaa48-f954-49d9-a1e3-e3e065fe93c7/download
http://repositorio.bc.ufg.br/tede/bitstreams/4f436744-fa72-417c-a171-b5891ae5f411/download
http://repositorio.bc.ufg.br/tede/bitstreams/75b3df75-b602-45be-8377-e20d353e0e32/download
bitstream.checksum.fl_str_mv bd3efa91386c1718a7f26a329fdcb468
4afdbb8c545fd630ea7db775da747b2f
ef48816a10f2d45f2e2fee2f478e2faf
9da0b6dfac957114c6a7714714b86306
bb8709720dbc4fb91db81ca23004d59d
5e263194c614bec1e9a82794359cf0e7
9c1001d0c2cad66da621f0290adbdd41
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)
repository.mail.fl_str_mv tasesdissertacoes.bc@ufg.br
_version_ 1798044374409412608